VIRAX BIOLABS GROUP LTD (VRAX) Stock Analyst Ratings
NASDAQ:VRAX • KYG9495L1251
0.213 USD
-0.01 (-5.33%)
At close: Feb 20, 2026
0.22 USD
+0.01 (+3.29%)
After Hours: 2/20/2026, 8:09:46 PM
ChartMill assigns a Buy % Consensus number of 83% to VRAX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.02. This target is 378.87% above the current price.
- VRAX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VRAX.
- VRAX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Initiate | Buy |
VIRAX BIOLABS GROUP LTD / VRAX FAQ
Can you provide the average price target for VIRAX BIOLABS GROUP LTD stock?
7 analysts have analysed VRAX and the average price target is 1.02 USD. This implies a price increase of 378.87% is expected in the next year compared to the current price of 0.213.
What is the consensus rating for VRAX stock?
The consensus rating for VIRAX BIOLABS GROUP LTD (VRAX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover VIRAX BIOLABS GROUP LTD (VRAX) stock?
The number of analysts covering VIRAX BIOLABS GROUP LTD (VRAX) is 7.